ASX - By Stock
|
WBT |
Re:
Running discussion on SP
|
|
ydqcau
|
9.1K |
3.7M |
65 |
08/08/24 |
08/08/24 |
ASX - By Stock
|
9.1K
|
3.7M
|
65
|
|
ASX - By Stock
|
IMM |
Re:
Media
|
|
ydqcau
|
122 |
64K |
4 |
18/07/24 |
18/07/24 |
ASX - By Stock
|
122
|
64K
|
4
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Positive results in TACTI-003 for 1L HNSCC cohort B patients
|
|
ydqcau
|
42 |
24K |
11 |
16/07/24 |
16/07/24 |
ASX - By Stock
|
42
|
24K
|
11
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Positive results in TACTI-003 for 1L HNSCC cohort B patients
|
|
ydqcau
|
42 |
24K |
10 |
12/07/24 |
12/07/24 |
ASX - By Stock
|
42
|
24K
|
10
|
|
ASX - By Stock
|
IMU |
Re:
Ann: First patient dosed in Phase 1 bile tract cancer trial
|
|
ydqcau
|
133 |
74K |
8 |
10/07/24 |
10/07/24 |
ASX - By Stock
|
133
|
74K
|
8
|
|
ASX - By Stock
|
IMU |
Re:
Ann: First patient dosed in Phase 1 bile tract cancer trial
|
|
ydqcau
|
133 |
74K |
5 |
10/07/24 |
10/07/24 |
ASX - By Stock
|
133
|
74K
|
5
|
|
ASX - By Stock
|
IMM |
Re:
Media
|
|
ydqcau
|
122 |
64K |
17 |
03/07/24 |
03/07/24 |
ASX - By Stock
|
122
|
64K
|
17
|
|
ASX - By Stock
|
IMM |
Re:
What have we got?
|
|
ydqcau
|
49 |
35K |
26 |
24/06/24 |
24/06/24 |
ASX - By Stock
|
49
|
35K
|
26
|
|
ASX - By Stock
|
IMM |
Re:
Media
|
|
ydqcau
|
122 |
64K |
1 |
17/06/24 |
17/06/24 |
ASX - By Stock
|
122
|
64K
|
1
|
|
ASX - By Stock
|
IMM |
Re:
Media
|
|
ydqcau
|
122 |
64K |
0 |
17/06/24 |
17/06/24 |
ASX - By Stock
|
122
|
64K
|
0
|
|
ASX - By Stock
|
BRN |
Re:
2024 BrainChip Discussion
|
|
ydqcau
|
10K |
4.2M |
5 |
06/06/24 |
06/06/24 |
ASX - By Stock
|
10K
|
4.2M
|
5
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Immutep completes institutional pro-rata offer & placement
|
|
ydqcau
|
44 |
18K |
6 |
05/06/24 |
05/06/24 |
ASX - By Stock
|
44
|
18K
|
6
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Immutep completes institutional pro-rata offer & placement
|
|
ydqcau
|
44 |
18K |
1 |
05/06/24 |
05/06/24 |
ASX - By Stock
|
44
|
18K
|
1
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Trading Halt
|
|
ydqcau
|
54 |
23K |
8 |
03/06/24 |
03/06/24 |
ASX - By Stock
|
54
|
23K
|
8
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Trading Halt
|
|
ydqcau
|
54 |
23K |
13 |
03/06/24 |
03/06/24 |
ASX - By Stock
|
54
|
23K
|
13
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Trading Halt
|
|
ydqcau
|
54 |
23K |
6 |
03/06/24 |
03/06/24 |
ASX - By Stock
|
54
|
23K
|
6
|
|
ASX - By Stock
|
IMM |
Re:
Media
|
|
ydqcau
|
122 |
64K |
12 |
01/06/24 |
01/06/24 |
ASX - By Stock
|
122
|
64K
|
12
|
|
ASX - By Stock
|
IMM |
Re:
Media
|
|
ydqcau
|
122 |
64K |
0 |
31/05/24 |
31/05/24 |
ASX - By Stock
|
122
|
64K
|
0
|
|
ASX - By Stock
|
IMM |
Re:
Ann: AIPAC-003 safety lead-in data presented at ESMO Breast 2024
|
|
ydqcau
|
16 |
8.4K |
10 |
15/05/24 |
15/05/24 |
ASX - By Stock
|
16
|
8.4K
|
10
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
ydqcau
|
2.8K |
1.2M |
19 |
15/05/24 |
15/05/24 |
ASX - By Stock
|
2.8K
|
1.2M
|
19
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
ydqcau
|
2.8K |
1.2M |
8 |
15/05/24 |
15/05/24 |
ASX - By Stock
|
2.8K
|
1.2M
|
8
|
|
ASX - By Stock
|
IMU |
Re:
Why IMU is a multi multi bagger
|
|
ydqcau
|
26K |
13M |
0 |
10/05/24 |
10/05/24 |
ASX - By Stock
|
26K
|
13M
|
0
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
ydqcau
|
2.8K |
1.2M |
7 |
08/05/24 |
08/05/24 |
ASX - By Stock
|
2.8K
|
1.2M
|
7
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
ydqcau
|
2.8K |
1.2M |
11 |
08/05/24 |
08/05/24 |
ASX - By Stock
|
2.8K
|
1.2M
|
11
|
|
ASX - By Stock
|
IMM |
Re:
Immutep has been featured in the latest Thematic Insights Report - Download now!
|
|
ydqcau
|
3 |
2.1K |
0 |
08/05/24 |
08/05/24 |
ASX - By Stock
|
3
|
2.1K
|
0
|
|
ASX - By Stock
|
IMM |
Re:
Immutep has been featured in the latest Thematic Insights Report - Download now!
|
|
ydqcau
|
3 |
2.1K |
7 |
08/05/24 |
08/05/24 |
ASX - By Stock
|
3
|
2.1K
|
7
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
ydqcau
|
2.8K |
1.2M |
19 |
08/05/24 |
08/05/24 |
ASX - By Stock
|
2.8K
|
1.2M
|
19
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Application for quotation of securities - IMU
|
|
ydqcau
|
17 |
8.2K |
8 |
06/05/24 |
06/05/24 |
ASX - By Stock
|
17
|
8.2K
|
8
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Positive initial data in phase 2 Soft Tissue Sarcoma trial
|
|
ydqcau
|
16 |
9.0K |
19 |
02/05/24 |
02/05/24 |
ASX - By Stock
|
16
|
9.0K
|
19
|
|
ASX - By Stock
|
WBT |
Re:
Charts
|
|
ydqcau
|
4.9K |
2.0M |
1 |
29/04/24 |
29/04/24 |
ASX - By Stock
|
4.9K
|
2.0M
|
1
|
|
ASX - By Stock
|
WBT |
Re:
Charts
|
|
ydqcau
|
4.9K |
2.0M |
6 |
29/04/24 |
29/04/24 |
ASX - By Stock
|
4.9K
|
2.0M
|
6
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Positive preliminary topline results from TACTI-003 Cohort B
|
|
ydqcau
|
51 |
26K |
15 |
24/04/24 |
24/04/24 |
ASX - By Stock
|
51
|
26K
|
15
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Positive preliminary topline results from TACTI-003 Cohort B
|
|
ydqcau
|
51 |
26K |
25 |
24/04/24 |
24/04/24 |
ASX - By Stock
|
51
|
26K
|
25
|
|
ASX - By Stock
|
IMM |
Re:
Media
|
|
ydqcau
|
743 |
347K |
3 |
10/04/24 |
10/04/24 |
ASX - By Stock
|
743
|
347K
|
3
|
|
ASX - By Stock
|
IMM |
Re:
Media
|
|
ydqcau
|
743 |
347K |
14 |
10/04/24 |
10/04/24 |
ASX - By Stock
|
743
|
347K
|
14
|
|
ASX - By Stock
|
IMM |
Re:
Media
|
|
ydqcau
|
743 |
347K |
13 |
10/04/24 |
10/04/24 |
ASX - By Stock
|
743
|
347K
|
13
|
|
ASX - By Stock
|
IMM |
Re:
Media
|
|
ydqcau
|
743 |
347K |
20 |
10/04/24 |
10/04/24 |
ASX - By Stock
|
743
|
347K
|
20
|
|
ASX - By Stock
|
IMM |
Re:
Media
|
|
ydqcau
|
743 |
347K |
11 |
08/04/24 |
08/04/24 |
ASX - By Stock
|
743
|
347K
|
11
|
|
ASX - By Stock
|
IMM |
Re:
Media
|
|
ydqcau
|
743 |
347K |
34 |
06/04/24 |
06/04/24 |
ASX - By Stock
|
743
|
347K
|
34
|
|
ASX - By Stock
|
IMM |
Re:
Media
|
|
ydqcau
|
743 |
347K |
24 |
05/04/24 |
05/04/24 |
ASX - By Stock
|
743
|
347K
|
24
|
|
ASX - By Stock
|
IMM |
Re:
Media
|
|
ydqcau
|
743 |
347K |
26 |
03/04/24 |
03/04/24 |
ASX - By Stock
|
743
|
347K
|
26
|
|
ASX - By Stock
|
IMM |
Re:
Media
|
|
ydqcau
|
743 |
347K |
9 |
25/03/24 |
25/03/24 |
ASX - By Stock
|
743
|
347K
|
9
|
|
ASX - By Stock
|
IMM |
Re:
Media
|
|
ydqcau
|
743 |
347K |
20 |
22/03/24 |
22/03/24 |
ASX - By Stock
|
743
|
347K
|
20
|
|
Charts
|
IMU Biotech |
Re:
IMUGENE CHART. TA only
|
|
ydqcau
|
34K |
17M |
3 |
20/03/24 |
20/03/24 |
Charts
|
34K
|
17M
|
3
|
|
ASX - By Stock
|
IMM |
Re:
Media
|
|
ydqcau
|
743 |
347K |
17 |
18/03/24 |
18/03/24 |
ASX - By Stock
|
743
|
347K
|
17
|
|
ASX - By Stock
|
WBT |
Re:
Running discussion on SP
|
|
ydqcau
|
9.1K |
3.7M |
0 |
15/03/24 |
15/03/24 |
ASX - By Stock
|
9.1K
|
3.7M
|
0
|
|
ASX - By Stock
|
IMM |
Re:
Ann: First Clinical Data announced from 90mg Dosing of Efti
|
|
ydqcau
|
56 |
32K |
13 |
15/03/24 |
15/03/24 |
ASX - By Stock
|
56
|
32K
|
13
|
|
ASX - By Stock
|
WBT |
Re:
Weebit - 2024 and beyond
|
|
ydqcau
|
1.9K |
860K |
30 |
14/03/24 |
14/03/24 |
ASX - By Stock
|
1.9K
|
860K
|
30
|
|
ASX - By Stock
|
IMM |
Re:
Ann: First Clinical Data announced from 90mg Dosing of Efti
|
|
ydqcau
|
56 |
32K |
9 |
14/03/24 |
14/03/24 |
ASX - By Stock
|
56
|
32K
|
9
|
|
ASX - By Stock
|
IMM |
Re:
Ann: First Clinical Data announced from 90mg Dosing of Efti
|
|
ydqcau
|
56 |
32K |
13 |
13/03/24 |
13/03/24 |
ASX - By Stock
|
56
|
32K
|
13
|
|